mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.09 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.05 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
0.22 |
0.1 |